Target intelligence / Profile preview

Sodium-dependent phosphate transporter 1 (SLC20A1) (SLC20A1)

Target
SLC20A1
Molecular classification
Transporter, Solute carrier family, Receptor
01

Overview

Sodium-dependent phosphate transporter 1 (SLC20A1), also known as PiT-1, is a 12-transmembrane protein that functions as a symporter, mediating the uptake of inorganic phosphate into cells using the electrochemical gradient of sodium (UniProt: P17701). It is ubiquitously expressed and plays a vital role in cellular metabolism, signal transduction, and bone mineralization (PubMed: 10852430). SLC20A1 is notably recognized as the primary host cell receptor for the Gibbon Ape Leukemia Virus (GALV) (PubMed: 1643592). The viral envelope glycoprotein (GALV-GP) interacts with the extracellular loops of SLC20A1 to trigger membrane fusion and viral entry. In the context of gene therapy, the R-peptide-deleted version of GALV-GP is frequently used to pseudotype viral vectors because it is constitutively fusogenic, allowing for efficient delivery of genetic material into SLC20A1-expressing target cells (PubMed: 11152503). While SLC20A1 is not a common target for traditional small-molecule drugs, its role in vascular calcification and its overexpression in various cancers make it a subject of therapeutic interest and a key determinant for the tropism of GALV-based biologics (PubMed: 23639503).

Other names
PiT-1GLVR1Gibbon ape leukemia virus receptor 1Solute carrier family 20 member 1PIT1Phosphate transporter 1
02

Mechanism of action

The target serves as a docking site for the GALV-GP envelope protein. Binding triggers conformational changes in the GP (especially when the R-peptide is absent) that lead to fusion between the viral envelope and the host cell membrane (PubMed: 11152503). Additionally, it transports inorganic phosphate into the cytoplasm (UniProt: P17701).

03

Biological functions

Phosphate ion transportViral entryBone mineralizationCell proliferationApoptosis regulation
04

Disease associations

InfectionVascular calcificationCancer
05

Safety considerations

Essential role in systemic phosphate homeostasisPotential for vascular calcification upon dysregulationWidespread expression may lead to off-target effects for viral vectors
06

Interacting drugs

GALV-pseudotyped retroviral vectors

2 more in the full profile.

07

Biomarkers

SLC20A1 expression level

Beyond the preview

Go deeper on Sodium-dependent phosphate transporter 1 (SLC20A1) (SLC20A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent phosphate transporter 1 (SLC20A1) (SLC20A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call